AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15312105 — intervention group
Group type: EXPERIMENTAL
Intervention: Oscillating/rotating powered toothbrush
Number of subjects: 40
Study 15312105 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 40
Study 10906914 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive massage therapy (n = 25)
Number of subjects: 98
Study 10906914 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft-tissue manipulation only (n = 25)
Number of subjects: 98
Study 10906914 — intervention group
Group type: EXPERIMENTAL
Intervention: Remedial exercise with posture education only (n = 22)
Number of subjects: 98
Study 10906914 — intervention group
Group type: COMPARATOR
Intervention: Sham laser therapy (n = 26)
Number of subjects: 98
Study 9217890 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion (3.5 mU/min) for 180 min in protocol I
Number of subjects: 22
Study 9217890 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion (100 mU/min) in hand veins in protocol III
Number of subjects: 22
Study 9217890 — intervention group
Group type: COMPARATOR
Intervention: Noradrenaline infusion (0.025, 0.01 and 0.4 microgram/min) at baseline, 90 and 180 min after insulin in protocol I
Number of subjects: 22
Study 9217890 — intervention group
Group type: COMPARATOR
Intervention: Noradrenaline infusion (1.7-55 ng/min) at baseline and at 90 and 180 min in protocol II
Number of subjects: 22
Study 8377448 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified BFM-protocol (ALL REZ I/88) with alternating courses of polychemotherapy including intermediate dose methotrexate (1 g/m2 in 36 hours) and maintenance treatment with daily oral thioguanine and biweekly IV MTX.
Number of subjects: 55
Study 8377448 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified BFM-protocol (ALL REZ I/88)
Number of subjects: 55
Study 3017033 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II (AII) infusion (5 ng/kg/min)
Number of subjects: 16
Study 3017033 — intervention group
Group type: COMPARATOR
Intervention: Sham infusion
Number of subjects: 16
Study 3017033 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II (AII) infusion (5 ng/kg/min) with o-CRH injection (100 micrograms)
Number of subjects: 16
Study 3017033 — intervention group
Group type: COMPARATOR
Intervention: Sham infusion with o-CRH injection (100 micrograms)
Number of subjects: 16
Study 31810893 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage radiation therapy (sRT)
Number of subjects: 1301
Study 28931344 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver sulfadiazine (SSD)-coated ureteral stents
Number of subjects: 126
Study 28931344 — intervention group
Group type: COMPARATOR
Intervention: Non-coated ureteral stents
Number of subjects: 126
Study 26383882 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg ondansetron
Number of subjects: 59
Study 26383882 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 59
Study 24951981 — intervention group
Group type: EXPERIMENTAL
Intervention: High-oleic peanuts (HOP)
Number of subjects: 71
Study 24951981 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional peanuts (CVP)
Number of subjects: 71
Study 24951981 — intervention group
Group type: COMPARATOR
Intervention: Control biscuits (CT)
Number of subjects: 71
Study 21499794 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral Therapy (ART)
Number of subjects: 1563
Study 20163872 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-induced chorioretinal venous anastomosis (L-CRA)
Number of subjects: 113
Study 20163872 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 113
Study 18234324 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive counseling for mammography
Number of subjects: 3557
Study 18234324 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive counseling for smoking
Number of subjects: 3557
Study 18234324 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive counseling for diet
Number of subjects: 3557
Study 18234324 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive counseling for sun protection
Number of subjects: 3557
Study 18234324 — intervention group
Group type: EXPERIMENTAL
Intervention: More thorough counseling across all behaviors
Number of subjects: 3557
Study 18234324 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior counseling
Number of subjects: 3557
Study 16117980 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 4 mg
Number of subjects: 80
Study 16117980 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg
Number of subjects: 80
Study 16117980 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 16 mg
Number of subjects: 80
Study 16117980 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 80
Study 14566347 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridoxine‐metoclopramide combination therapy
Number of subjects: 174
Study 14566347 — intervention group
Group type: COMPARATOR
Intervention: Prochlorperazine
Number of subjects: 174
Study 14566347 — intervention group
Group type: COMPARATOR
Intervention: Promethazine
Number of subjects: 174
Study 10364869 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol and ondansetron
Number of subjects: 4
Study 10364869 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl and ondansetron
Number of subjects: 4
Study 10364869 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol and metoclopramide
Number of subjects: 4
Study 10364869 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl and metoclopramide
Number of subjects: 4
Study 8558221 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 100 mg/m2 administered over 1 hour every 21 days
Number of subjects: 37
Study 8558221 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 100 mg/m2
Number of subjects: 37
Study 1992912 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-interferon (IFN), ACNU, and Radiation
Number of subjects: 120
Study 1992912 — intervention group
Group type: COMPARATOR
Intervention: ACNU and Radiation
Number of subjects: 120
Study 1992912 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-interferon (IFN) therapy
Number of subjects: 120
Study 6441010 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of intravenous metoclopramide administered 10 min prior to nasal insertion of a weighed feeding tube
Number of subjects: 10
Study 6441010 — intervention group
Group type: COMPARATOR
Intervention: No premedication (Control)
Number of subjects: 10
Study 30720004 — intervention group
Group type: EXPERIMENTAL
Intervention: SignaturePFS-CG (combination of clinical factors and COX-2/C-MET/KRAS expression status)
Number of subjects: 578
Study 30720004 — intervention group
Group type: EXPERIMENTAL
Intervention: SignatureOS-CG (combination of clinical factors and COX-2/C-MET/KRAS expression status)
Number of subjects: 578
Study 29432125 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 38
Study 29432125 — intervention group
Group type: COMPARATOR
Intervention: Intensive medical diabetes and weight management (IMWM)
Number of subjects: 38
Study 29432125 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall quality of life
Number of subjects: 38
Study 27123881 — intervention group
Group type: EXPERIMENTAL
Intervention: Embedded vocabulary and comprehension lessons during storybook reading
Number of subjects: 195
Study 27123881 — intervention group
Group type: COMPARATOR
Intervention: Standard storybook reading without embedded lessons
Number of subjects: 195
Study 27123881 — intervention group
Group type: EXPERIMENTAL
Intervention: Embedded vocabulary and comprehension lessons
Number of subjects: 195
Study 25182660 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive dipyridamole 75 mg twice daily
Number of subjects: 91
Study 25182660 — intervention group
Group type: COMPARATOR
Intervention: Double-dose clopidogrel 150 mg daily
Number of subjects: 91
Study 25182660 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (DIP and DOUBLE)
Number of subjects: 91
Study 25182660 — intervention group
Group type: EXPERIMENTAL
Intervention: DIP group
Number of subjects: 91
Study 25182660 — intervention group
Group type: EXPERIMENTAL
Intervention: DOUBLE group
Number of subjects: 91
Study 22596208 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine (10 mg)
Number of subjects: 32
Study 22596208 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 18973887 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro‐TESE (microdissection testicular sperm extraction) followed by intracytoplasmic sperm injection
Number of subjects: 792
Study 16799799 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 500 microg twice daily for 12 months
Number of subjects: 27
Study 16799799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 15023828 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 401
Study 12487201 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin prick tests (SPTs) with commercial beef extracts
Number of subjects: 34
Study 12487201 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin prick tests (SPTs) with fresh beef
Number of subjects: 34
Study 12487201 — intervention group
Group type: COMPARATOR
Intervention: Literature review on skin prick tests for cow's milk
Number of subjects: 34
Study 9500626 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 205
Study 9500626 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 205
Study 7716316 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography (US)
Number of subjects: 178
Study 7716316 — intervention group
Group type: COMPARATOR
Intervention: Barium swallow
Number of subjects: 178
Study 2664817 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmentin (1.2 g intravenously 3-times daily for a mean of 6.6 days, then 375 mg orally for a further 6.4 days)
Number of subjects: 104
Study 2664817 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (1 g cefazoline intravenously 4-times daily plus 500 mg metronidazole intravenously 3-times daily for 7 days, then 500 mg cefadroxil orally 4-times daily for a mean of 6.6 days)
Number of subjects: 104
Study 124721 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate reinforcement
Number of subjects: 44
Study 124721 — intervention group
Group type: COMPARATOR
Intervention: End-of-session reinforcement
Number of subjects: 44
Study 124721 — intervention group
Group type: COMPARATOR
Intervention: Noncontingent reinforcement
Number of subjects: 44
Study 124721 — intervention group
Group type: COMPARATOR
Intervention: Delayed reinforcement
Number of subjects: 44
Study 31833150 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis use
Number of subjects: 126291
Study 31833150 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis use and depression genetic correlation
Number of subjects: 126291
Study 31833150 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic risk scores for cannabis use and depression
Number of subjects: 126291
Study 31833150 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-sample Mendelian randomization analyses
Number of subjects: 126291
Study 31724363 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction teaching mode integrated with virtual anatomy platform
Number of subjects: 60
Study 31724363 — intervention group
Group type: COMPARATOR
Intervention: Traditional practical teaching mode
Number of subjects: 60
Study 31724363 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 29275583 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone (0.2 mg/kg) combined with dexmedetomidine (loading dose of 0.5 μg/kg for 10 minutes and continuous infusion of 0.2 μg·kg(‐1)·h(‐1))
Number of subjects: 60
Study 29275583 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl (2 μg/kg) combined with dexmedetomidine
Number of subjects: 60
Study 25171115 — intervention group
Group type: EXPERIMENTAL
Intervention: LARS procedure
Number of subjects: 41
Study 25171115 — intervention group
Group type: COMPARATOR
Intervention: MBG procedure
Number of subjects: 41
Study 23919441 — intervention group
Group type: EXPERIMENTAL
Intervention: Coarse concentrated ambient particles (CAP) exposure for 2 hours
Number of subjects: 32
Study 23919441 — intervention group
Group type: COMPARATOR
Intervention: Filtered air (FA) exposure for 2 hours
Number of subjects: 32
Study 21701083 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA plus statin (1,800 mg/day)
Number of subjects: 50
Study 21701083 — intervention group
Group type: COMPARATOR
Intervention: Statin-only
Number of subjects: 50
Study 18307781 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training programme (4 times a week for 8 weeks, initial intensity 65% VO2 peak)
Number of subjects: 20
Study 18307781 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training programme
Number of subjects: 20
Study 18307781 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintained current physical activity level)
Number of subjects: 20
Study 16930364 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba (160 mg daily dose)
Number of subjects: 0
Study 16930364 — intervention group
Group type: EXPERIMENTAL
Intervention: donepezil (5 mg daily dose)
Number of subjects: 0
Study 16930364 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 15468547 — intervention group
Group type: EXPERIMENTAL
Intervention: Trasylol (T) 6 mln KIU administered from patient's admission to surgery room until skin incision, plus 2 mln KIU from surgical approach to beginning of AC, added to ACA.
Number of subjects: 73
Study 15468547 — intervention group
Group type: EXPERIMENTAL
Intervention: Trasylol (T) 3 mln KIU administered similarly to group 1 but not added to ACA.
Number of subjects: 73
Study 15468547 — intervention group
Group type: COMPARATOR
Intervention: No Trasylol (T) used.
Number of subjects: 73
Study 11401884 — intervention group
Group type: EXPERIMENTAL
Intervention: OSLER test after sleep-deprived night
Number of subjects: 10
Study 11401884 — intervention group
Group type: COMPARATOR
Intervention: OSLER test after non-sleep-deprived night
Number of subjects: 10
Study 11401884 — intervention group
Group type: EXPERIMENTAL
Intervention: OSLER test
Number of subjects: 10
Study 9144689 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg/m2 and epirubicin 60 mg/m2 (Group A)
Number of subjects: 68
Study 9144689 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg/m2 and epirubicin 90 mg/m2 (Group B)
Number of subjects: 68
Study 8175327 — intervention group
Group type: EXPERIMENTAL
Intervention: Surfactant treatment
Number of subjects: 31
Study 8175327 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (positive pressure ventilation and supportive care)
Number of subjects: 31
Study 2885189 — intervention group
Group type: COMPARATOR
Intervention: Vecuronium
Number of subjects: 0
Study 2885189 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 0
Study 29695226 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminders only
Number of subjects: 196
Study 29695226 — intervention group
Group type: COMPARATOR
Intervention: Incentives only
Number of subjects: 196
Study 29695226 — intervention group
Group type: COMPARATOR
Intervention: Incentives and reminders
Number of subjects: 196
Study 29695226 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 196
Study 28485264 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g NWT-03
Number of subjects: 92
Study 28485264 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g NWT-03
Number of subjects: 92
Study 28485264 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 25472864 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic intravenous fluid containing 140 mmol/L of sodium (Na140)
Number of subjects: 690
Study 25472864 — intervention group
Group type: COMPARATOR
Intervention: Hypotonic fluid containing 77 mmol/L of sodium (Na77)
Number of subjects: 690
Study 23744959 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 23744959 — intervention group
Group type: COMPARATOR
Intervention: 0.75 mg·kg(‐1) lidocaine
Number of subjects: 90
Study 23744959 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg·kg(‐1) lidocaine
Number of subjects: 90
Study 20638884 — intervention group
Group type: EXPERIMENTAL
Intervention: New Helicobacter infections
Number of subjects: 124
Study 20638884 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Helicobacter infections
Number of subjects: 124
Study 20638884 — intervention group
Group type: COMPARATOR
Intervention: Uninfected controls
Number of subjects: 124
Study 20638884 — intervention group
Group type: EXPERIMENTAL
Intervention: Helicobacter infections (overall)
Number of subjects: 124
Study 22073476 — intervention group
Group type: EXPERIMENTAL
Intervention: Lingual orthodontic appliances
Number of subjects: 60
Study 22073476 — intervention group
Group type: COMPARATOR
Intervention: Labial orthodontic appliances
Number of subjects: 60
Study 16316789 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (new formulation)
Number of subjects: 0
Study 16316789 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12679775 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenax stent (a‐SiC:H coated)
Number of subjects: 497
Study 12679775 — intervention group
Group type: COMPARATOR
Intervention: Nir stent (316L stainless steel)
Number of subjects: 497
Study 10743863 — intervention group
Group type: EXPERIMENTAL
Intervention: Resorbable citric acid ester softened polylactic acid membranes (RM)
Number of subjects: 29
Study 10743863 — intervention group
Group type: COMPARATOR
Intervention: Non‐resorbable expanded polytetrafluoroethylene (ePTFE) barriers (NRM)
Number of subjects: 29
Study 8959471 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (LZ)
Number of subjects: 7
Study 8959471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 1490923 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B mixed with Intralipid (0.7‐1 mg/kg/day)
Number of subjects: 32
Study 1490923 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B in 5% dextrose (0.7‐1 mg/kg/day)
Number of subjects: 32
Study 3899676 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (DZ) 10 mg
Number of subjects: 9
Study 3899676 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (LZ) 2.5 mg
Number of subjects: 9
Study 3899676 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 9
Study 3899676 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol 1 g/kg
Number of subjects: 9
Study 29774768 — intervention group
Group type: EXPERIMENTAL
Intervention: Boswellia serrata gum resin (250 mg twice daily for 8 weeks)
Number of subjects: 56
Study 29774768 — intervention group
Group type: COMPARATOR
Intervention: Placebo (250 mg twice daily for 8 weeks)
Number of subjects: 56
Study 27677810 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered toothbrush
Number of subjects: 60
Study 27677810 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 60
Study 24307259 — intervention group
Group type: EXPERIMENTAL
Intervention: Endorsement of the Affordable Care Act (ACA)
Number of subjects: 3897
Study 24307259 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception of reimbursement fairness under ACA
Number of subjects: 3897
Study 24307259 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional obligation to address societal health policy issues
Number of subjects: 3897
Study 24307259 — intervention group
Group type: EXPERIMENTAL
Intervention: Obligation to care for the uninsured or underinsured
Number of subjects: 3897
Study 24307259 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness to accept limits on coverage for expensive drugs and procedures
Number of subjects: 3897
Study 24307259 — intervention group
Group type: EXPERIMENTAL
Intervention: Endorsement of ACA by political affiliation
Number of subjects: 3897
Study 24307259 — intervention group
Group type: EXPERIMENTAL
Intervention: Endorsement of ACA by compensation type
Number of subjects: 3897
Study 24307259 — intervention group
Group type: EXPERIMENTAL
Intervention: Agreement with professional obligations regarding societal health policy
Number of subjects: 3897
Study 24307259 — intervention group
Group type: EXPERIMENTAL
Intervention: Belief in obligation to care for uninsured/underinsured
Number of subjects: 3897
Study 24307259 — intervention group
Group type: EXPERIMENTAL
Intervention: Agreement with limiting coverage for expensive drugs and procedures
Number of subjects: 3897
Study 24307259 — intervention group
Group type: EXPERIMENTAL
Intervention: Endorsement of ACA by specialty
Number of subjects: 3897
Study 22537843 — intervention group
Group type: EXPERIMENTAL
Intervention: High dexmedetomidine concentration group
Number of subjects: 120
Study 22537843 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dexmedetomidine concentration group
Number of subjects: 120
Study 22537843 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 120
Study 20732849 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol/hydrocortisone combination ointment (calcipotriol 25 mcg/g or 50 mcg/g combined with hydrocortisone 10 mg/g)
Number of subjects: 0
Study 20732849 — intervention group
Group type: COMPARATOR
Intervention: Calcipotriol alone (25 mcg/g or 50 mcg/g)
Number of subjects: 0
Study 20732849 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol/hydrocortisone combination ointment
Number of subjects: 0
Study 18172136 — intervention group
Group type: EXPERIMENTAL
Intervention: Community drama ('skits') intervention
Number of subjects: 0
Study 18172136 — intervention group
Group type: COMPARATOR
Intervention: Control group (adults who did not witness the skits)
Number of subjects: 0
Study 15910620 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E 800 IU/day
Number of subjects: 28
Study 15910620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 12008940 — intervention group
Group type: EXPERIMENTAL
Intervention: Venography
Number of subjects: 66
Study 12008940 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 66
Study 10983060 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity laser therapy; duration not specified.
Number of subjects: 0
Study 10983060 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified; no control intervention mentioned.
Number of subjects: 0